Development of tobacco smoke-induced lung tumors in mice fed Bowman-Birk protease inhibitor concentrate (BBIC)
Authors:
- Hanspeter WitschiHWHanspeter Witschi
- Imelda EspirituIEImelda Espiritu
- 1 September 2002
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 183 (2) , 141-146
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Lung Epithelial Proliferation: a Biomarker for Chemoprevention Trials?JNCI: Journal of the National Cancer Institute, 2001
- Effects of Bowman–Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia*†The Prostate, 2001
- SUCCESSFUL AND NOT SO SUCCESSFUL CHEMOPREVENTION OF TOBACCO SMOKE-INDUCED LUNG TUMORSExperimental Lung Research, 2000
- The effects of phenethyl isothiocyanate, N-acetylcysteine and green tea on tobacco smoke-induced lung tumors in strain A/J miceCarcinogenesis, 1998
- Chemopreventive AgentsPharmacology & Therapeutics, 1998
- Sidestream Cigarette Smoke Generation and Exposure System for Environmental Tobacco Smoke StudiesInhalation Toxicology, 1994
- AIN-93 Purified Diets for Laboratory Rodents: Final Report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent DietThe Journal of Nutrition, 1993
- Cationized Bowman-Birk Protease Inhibitor as a Targeted Cancer Chemopreventive AgentJournal of Drug Targeting, 1993
- Preparation and production of a cancer chemopreventive agent, Bowman‐Birk inhibitor concentrateNutrition and Cancer, 1993
- Inhibition of N-nitrosomethylbenzylamine-induced esophageal neoplasms by the Bowman-Birk protease inhibitorCarcinogenesis, 1991